![overlay-bottom[1]](https://ambrygen.com/wp-content/uploads/2026/02/overlay-bottom1.svg)
Articles Tagged: NCCN
June 26, 2025
Building Trust in Digital Screening: Validating CARE’s Hereditary Cancer Risk Assessment
Rob Pilarski shares validation results for Ambry’s CARE Program® (CARE), recently published in the Journal of the National Comprehensive Cancer Network.
Breast Cancer
Genetic Testing
NCCN
Ovarian Cancer
April 12, 2023
Ambry Spotlights Rob Pilarski: Seeing Genetic Testing’s Big Picture
Robert Pilarski, MS, LGC, MSW, Director of Medical Affairs, discusses his background and work with NCCN and ensuring the guidelines for genetic testing are met…
Genetic Testing
NCCN
March 8, 2023
International Women’s Day: Spotlighting Cathrine Keller, MD, A Woman of Substance
Ambry recognizes Dr. Cathrine Keller of Lake Medical Imaging for International Women’s Day. She shares her history, passion for radiology and how technology has led…
Breast Cancer
Genetic Testing
NCCN
Ovarian Cancer
Screening
April 14, 2017
Ambry Genetics and Leading Academic Researchers Collaborate to Improve Knowledge of Genetic Risk Factors for Breast Cancer
Mayo Clinic and Dr. Fergus Couch collaborate with Ambry Genetics in the largest genetic study to date of women with breast cancer.
ATM
BARD1
BRCA1 & 2
Breast Cancer
CHEK2
HBOC
Mayo Clinic
NCCN
PALB2
RAD51D
